Supersensitivity to apomorphine following destruction of the ascending dopamine neurons: quantification using the rotational model
- PMID: 557411
- DOI: 10.1016/0014-2999(77)90256-4
Supersensitivity to apomorphine following destruction of the ascending dopamine neurons: quantification using the rotational model
Abstract
A new surgical preparation is described with which it is possible to quantify the degree of supersensitivity to dopamine receptor-stimulating agents using the rotational model. One group of rats received a unilateral injection of 6-hydroxydopamine which destroys the dopamine-containing neurons in one hemisphere, followed by a diencephalic electrocoagulation which interrupts both afferents and efferents of the striato-pallidal complex in the opposite hemisphere. Another series of animals received only the unilateral electrocoagulation. When given appomorphine both groups of animals rotated toward the side of the electrocoagulation. However, the 6-hdroxydopamine-treated animals were 10-40 times more sensitive to the behavioral effect of the drug. These results contrast with previous reports in which behavioral sensitivity to apomorphine was increased 2- to 7-fold following partial degeneration of central dopamine neurons of following the chronic adminstration of dopamine synthesis inhibitors of receptor blocking agents. The extent of loss of dopamine appears to be a critical factor in determining the degree of supersensitivity which will develop.
Similar articles
-
Striatal cell supersensitivity to apomorphine in dopamine-lesioned rats correlated to behaviour.Neuropharmacology. 1978 Jun;17(6):349-53. doi: 10.1016/0028-3908(78)90005-9. Neuropharmacology. 1978. PMID: 566861 No abstract available.
-
Behavioral quantification of striatal dopaminergic supersensitivity after bilateral 6-hydroxydopamine lesions in the mouse.Pharmacol Biochem Behav. 1992 Feb;41(2):343-7. doi: 10.1016/0091-3057(92)90108-r. Pharmacol Biochem Behav. 1992. PMID: 1574523
-
The 6-hydroxydopamine rotational model for the detection of dopamine agonist activity: reliability of effect from different locations of 6-hydroxydopamine.J Pharm Pharmacol. 1975 Dec;27(12):943-6. doi: 10.1111/j.2042-7158.1975.tb10253.x. J Pharm Pharmacol. 1975. PMID: 2668 No abstract available.
-
Rotational behaviour in rats with unilateral striatal kainic acid lesions: a behavioural model for studies on intact dopamine receptors.Brain Res. 1979 Jul 20;170(3):485-95. doi: 10.1016/0006-8993(79)90966-1. Brain Res. 1979. PMID: 37986
-
Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.Synapse. 1992 Mar;10(3):206-16. doi: 10.1002/syn.890100304. Synapse. 1992. PMID: 1532677
Cited by
-
Rodent Models of Alzheimer's Disease: Past Misconceptions and Future Prospects.Int J Mol Sci. 2024 Jun 5;25(11):6222. doi: 10.3390/ijms25116222. Int J Mol Sci. 2024. PMID: 38892408 Free PMC article. Review.
-
Striatal dopamine in motor activation and reward-mediated learning: steps towards a unifying model.J Neural Transm Gen Sect. 1990;80(1):9-31. doi: 10.1007/BF01245020. J Neural Transm Gen Sect. 1990. PMID: 2407269 Review.
-
Aminochrome as a preclinical experimental model to study degeneration of dopaminergic neurons in Parkinson's disease.Neurotox Res. 2007 Sep;12(2):125-34. doi: 10.1007/BF03033921. Neurotox Res. 2007. PMID: 17967736 Review.
-
A novel skilled-reaching impairment in paw supination on the "good" side of the hemi-Parkinson rat improved with rehabilitation.J Neurosci. 2003 Jan 15;23(2):579-86. doi: 10.1523/JNEUROSCI.23-02-00579.2003. J Neurosci. 2003. PMID: 12533618 Free PMC article.
-
Systemically circulating 17β-estradiol enhances the neuroprotective effect of the smoking cessation drug cytisine in female parkinsonian mice.NPJ Parkinsons Dis. 2025 Jan 3;11(1):6. doi: 10.1038/s41531-024-00855-3. NPJ Parkinsons Dis. 2025. PMID: 39753582 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources